Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility

Mol Cell Biol. 1999 Apr;19(4):3125-35. doi: 10.1128/MCB.19.4.3125.

Abstract

The coordinated interplay of substrate adhesion and deadhesion is necessary for cell motility. Using MCF-7 cells, we found that insulin-like growth factor I (IGF-I) induces the adhesion of MCF-7 to vitronectin and collagen in a dose- and time-dependent manner, suggesting that IGF-I triggers the activation of different integrins. On the other hand, IGF-I promotes the association of insulin receptor substrate 1 with the focal adhesion kinase (FAK), paxillin, and the tyrosine phosphatase SHP-2, resulting in FAK and paxillin dephosphorylation. Abrogation of SHP-2 catalytic activity with a dominant-negative mutant (SHP2-C>S) abolishes IGF-I-induced FAK dephosphorylation, and cells expressing SHP2-C>S show reduced IGF-I-stimulated chemotaxis compared with either mock- or SHP-2 wild-type-transfected cells. This impairment of cell migration is recovered by reintroduction of a catalytically active SHP-2. Interestingly, SHP-2-C>S cells show a larger number of focal adhesion contacts than wild-type cells, suggesting that SHP-2 activity participates in the integrin deactivation process. Although SHP-2 regulates mitogen-activated protein kinase activity, the mitogen-activated protein kinase kinase inhibitor PD-98059 has only a marginal effect on MCF-7 cell migration. The role of SHP-2 as a general regulator of cell chemotaxis induced by other chemotactic agents and integrins is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion / physiology
  • Cell Adhesion Molecules / metabolism*
  • Cell Movement / physiology*
  • Chemokine CCL5 / pharmacology
  • Chemotactic Factors / metabolism
  • Chemotaxis / physiology
  • Cytoskeletal Proteins / metabolism
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • Humans
  • Insulin Receptor Substrate Proteins
  • Insulin-Like Growth Factor I / pharmacology*
  • Integrins / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Models, Biological
  • Neoplasm Invasiveness
  • Paxillin
  • Phosphoproteins / metabolism
  • Phosphorylation
  • Protein Binding
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / metabolism*
  • Protein-Tyrosine Kinases / metabolism*
  • Receptor Cross-Talk / physiology*
  • Receptor, IGF Type 1 / metabolism
  • Signal Transduction
  • Tumor Cells, Cultured

Substances

  • Cell Adhesion Molecules
  • Chemokine CCL5
  • Chemotactic Factors
  • Cytoskeletal Proteins
  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • Integrins
  • Intracellular Signaling Peptides and Proteins
  • PXN protein, human
  • Paxillin
  • Phosphoproteins
  • Insulin-Like Growth Factor I
  • Protein-Tyrosine Kinases
  • Receptor, IGF Type 1
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK2 protein, human
  • PTPN11 protein, human
  • PTPN6 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases